We start 2026 with a strong presence across leading European conferences, sharing recent advances in antibody discovery through talks and posters.
📍 Where to meet us:
International Biotherapy Days – Toulouse, France | Jan 28–30
Sylvain Yon will be giving an oral presentation highlighting one of our lead assets : “First-in-class anti-TRPV6 antibody as a new therapeutic agent in cancer”
A key European meeting dedicated to biotherapies, spanning antibodies, cell and gene therapies, with strong academic–industrial interaction.
PSCC Innovation Forum – Paris, France | Feb 4
Cécile Durand and Sylvain Yon will be attending the forum.
1-day forum organised by the Paris-Saclay Cancer Cluster (PSCC) dedicated to oncology innovation, scientific exchange, and ecosystem collaboration
FORTRESS – Leuven, Belgium | Feb 12–13
Johanna Marines has been invited to give an oral presentation and present a poster on a First-in-class antibody in sarcoma.
A specialized congress on antibody formats, protein engineering, developability, and sarcomas, with a strong emphasis on early-stage R&D.
World ADC Congress – London, UK | Feb 23–26
Anne Chevrel will present a poster on a pH-sensitive ADC in lead optimization stage. Our Head of Discovery & Technology will be accompanied by Cécile Durand and Sylvain Yon.
The largest global event dedicated to antibody–drug conjugates, covering discovery, linker–payload technologies, and clinical translation.
ESMO Targeted Anticancer Therapies Congress – Paris, France | March 16–18
Tristan Mangeat & Baptiste Gouyou will present the poster #325 : Development of a tumor-specific anti-TRPV6 therapeutic antibody in metastatic prostate cancer indication
A reference oncology congress focused on novel targets, precision medicines, and early clinical development.
RESI Europe – Lisbon, Portugal | March 23
Sylvain Yon will meet partners and investors during the conference.
An investor-focused partnering conference connecting biotech innovators with pharma, VCs, and strategic partners.
🔗 Attending one of these? Send us an email
